| Company/Division name | Cobra Biologics |
| Parent company | Cognate BioServices, Inc. |
| Type of work | Manufacturing |
| If manufacturing, is the company a contract manufacturer? | Yes |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 550 |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2021 |
| Domestically, the work will be done: | In-house |
| City reshored to: | Memphis |
| State(s) reshored to: | TN |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | living therapeutics, viral vectors, plasmid DNA |
| What domestic positive factors made reshoring more attractive? | Infrastructure, Lead time/Time to market, Under-utilized capacity |
